Earnings Beat: CCL Products (India) Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

CCL Products (India) Limited (NSE:CCL) investors will be delighted, with the company turning in some strong numbers with its latest results. It was a solid earnings report, with revenues and statutory earnings per share (EPS) both coming in strong. Revenues were 15% higher than the analysts had forecast, at ₹11b, while EPS were ₹7.56 beating analyst models by 59%. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on CCL Products (India) after the latest results.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Taking into account the latest results, the most recent consensus for CCL Products (India) from nine analysts is for revenues of ₹41.1b in 2026. If met, it would imply a notable 8.6% increase on its revenue over the past 12 months. Per-share earnings are expected to ascend 13% to ₹28.50. Yet prior to the latest earnings, the analysts had been anticipated revenues of ₹37.2b and earnings per share (EPS) of ₹26.57 in 2026. The analysts seem more optimistic after the latest results, with a nice increase in revenue and a small lift in earnings per share estimates.

Check out our latest analysis for CCL Products (India)

It will come as no surprise to learn that the analysts have increased their price target for CCL Products (India) 9.0% to ₹1,037on the back of these upgrades. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. The most optimistic CCL Products (India) analyst has a price target of ₹1,231 per share, while the most pessimistic values it at ₹789. There are definitely some different views on the stock, but the range of estimates is not wide enough as to imply that the situation is unforecastable, in our view.

Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. We would highlight that CCL Products (India)'s revenue growth is expected to slow, with the forecast 18% annualised growth rate until the end of 2026 being well below the historical 24% p.a. growth over the last five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 9.8% annually. So it's pretty clear that, while CCL Products (India)'s revenue growth is expected to slow, it's still expected to grow faster than the industry itself.

The Bottom Line

The biggest takeaway for us is the consensus earnings per share upgrade, which suggests a clear improvement in sentiment around CCL Products (India)'s earnings potential next year. Happily, they also upgraded their revenue estimates, and are forecasting them to grow faster than the wider industry. There was also a nice increase in the price target, with the analysts clearly feeling that the intrinsic value of the business is improving.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for CCL Products (India) going out to 2028, and you can see them free on our platform here..

You still need to take note of risks, for example - CCL Products (India) has 2 warning signs we think you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.